This mutation has been previously associated with two distinct cardiac arrhythmias: Mutant gene carriers presented with LQT3, an SCN5A channelopathy associated with enhanced Na+ channel activity, and with CCD, associated with loss-of-function in the cardiac Na+ channel [29]. Here, SCN5A is linked to channelopathy.